Accessi venosi centrali a lungo termine in oncologia. Revisione di una casistica relativa a 750 casi

Translated title of the contribution: Long-term central venous access in oncology - Survey of 750 cases

S. Bertoglio, P. Meszsaros, C. Disomma, L. Moresco, F. Cafiero, M. Gipponi, P. Percivale

Research output: Contribution to journalArticle

Abstract

Totally implantable central venous accesses systems are presently widely used in cancer patients. Perioperative and long-term morbidity of 750 consecutive implants performed from 1985 to 1994 were retrospectively reviewed. Our Series consisted in 616 (82.1%). Ports and 134 (17.9%) external tunnelled catheters with subcutaneous Dacron cuff (Hickmann or similar catheters) implanted by percutaneous access route in local anesthesia. Subclavian vein was the elective access route in 700 (93.3%) patients while in the remaining 50 (6.7%) the access was performed in the femoral vein, due to peculiar clinical conditions. One-day surgery was only required for 19 (2.6%) patients while outpatient surgey was the routine in 731 (97.4%) patients. Perioperative morbidity was at all similar both for Port and external catheters Series (p > 0.07). Late morbidity requiring the removal of the device occurred in 27/134 patients (18.7%) and in 40/616 (6.5%) for external catheters and Port Series, respectively (p <0.002). The rate of infection, 2.3% for ports (p <0.002). Patient's compliance was higher for Ports compared to external cathethers. Apart from peculiar clinical conditions such as hemathologic cancers, bone marrow transplantation or short life expectancy, Ports seem to guarantee for a lower morbidity coupled with better long-term results.

Original languageItalian
Pages (from-to)427-431
Number of pages5
JournalMinerva Chirurgica
Volume51
Issue number6
Publication statusPublished - Jun 1996

Fingerprint

Morbidity
Vascular Access Devices
Catheters
Device Removal
Subclavian Vein
Bone Neoplasms
Polyethylene Terephthalates
Femoral Vein
Local Anesthesia
Patient Compliance
Life Expectancy
Bone Marrow Transplantation
Ambulatory Surgical Procedures
Outpatients
Surveys and Questionnaires
Infection
Neoplasms

ASJC Scopus subject areas

  • Surgery

Cite this

Bertoglio, S., Meszsaros, P., Disomma, C., Moresco, L., Cafiero, F., Gipponi, M., & Percivale, P. (1996). Accessi venosi centrali a lungo termine in oncologia. Revisione di una casistica relativa a 750 casi. Minerva Chirurgica, 51(6), 427-431.

Accessi venosi centrali a lungo termine in oncologia. Revisione di una casistica relativa a 750 casi. / Bertoglio, S.; Meszsaros, P.; Disomma, C.; Moresco, L.; Cafiero, F.; Gipponi, M.; Percivale, P.

In: Minerva Chirurgica, Vol. 51, No. 6, 06.1996, p. 427-431.

Research output: Contribution to journalArticle

Bertoglio, S, Meszsaros, P, Disomma, C, Moresco, L, Cafiero, F, Gipponi, M & Percivale, P 1996, 'Accessi venosi centrali a lungo termine in oncologia. Revisione di una casistica relativa a 750 casi', Minerva Chirurgica, vol. 51, no. 6, pp. 427-431.
Bertoglio S, Meszsaros P, Disomma C, Moresco L, Cafiero F, Gipponi M et al. Accessi venosi centrali a lungo termine in oncologia. Revisione di una casistica relativa a 750 casi. Minerva Chirurgica. 1996 Jun;51(6):427-431.
Bertoglio, S. ; Meszsaros, P. ; Disomma, C. ; Moresco, L. ; Cafiero, F. ; Gipponi, M. ; Percivale, P. / Accessi venosi centrali a lungo termine in oncologia. Revisione di una casistica relativa a 750 casi. In: Minerva Chirurgica. 1996 ; Vol. 51, No. 6. pp. 427-431.
@article{1ef36a8410df425f8519c7c9f6009aff,
title = "Accessi venosi centrali a lungo termine in oncologia. Revisione di una casistica relativa a 750 casi",
abstract = "Totally implantable central venous accesses systems are presently widely used in cancer patients. Perioperative and long-term morbidity of 750 consecutive implants performed from 1985 to 1994 were retrospectively reviewed. Our Series consisted in 616 (82.1{\%}). Ports and 134 (17.9{\%}) external tunnelled catheters with subcutaneous Dacron cuff (Hickmann or similar catheters) implanted by percutaneous access route in local anesthesia. Subclavian vein was the elective access route in 700 (93.3{\%}) patients while in the remaining 50 (6.7{\%}) the access was performed in the femoral vein, due to peculiar clinical conditions. One-day surgery was only required for 19 (2.6{\%}) patients while outpatient surgey was the routine in 731 (97.4{\%}) patients. Perioperative morbidity was at all similar both for Port and external catheters Series (p > 0.07). Late morbidity requiring the removal of the device occurred in 27/134 patients (18.7{\%}) and in 40/616 (6.5{\%}) for external catheters and Port Series, respectively (p <0.002). The rate of infection, 2.3{\%} for ports (p <0.002). Patient's compliance was higher for Ports compared to external cathethers. Apart from peculiar clinical conditions such as hemathologic cancers, bone marrow transplantation or short life expectancy, Ports seem to guarantee for a lower morbidity coupled with better long-term results.",
keywords = "Central venous access, Infection, Neoplasms, Surgery",
author = "S. Bertoglio and P. Meszsaros and C. Disomma and L. Moresco and F. Cafiero and M. Gipponi and P. Percivale",
year = "1996",
month = "6",
language = "Italian",
volume = "51",
pages = "427--431",
journal = "Minerva Chirurgica",
issn = "0026-4733",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "6",

}

TY - JOUR

T1 - Accessi venosi centrali a lungo termine in oncologia. Revisione di una casistica relativa a 750 casi

AU - Bertoglio, S.

AU - Meszsaros, P.

AU - Disomma, C.

AU - Moresco, L.

AU - Cafiero, F.

AU - Gipponi, M.

AU - Percivale, P.

PY - 1996/6

Y1 - 1996/6

N2 - Totally implantable central venous accesses systems are presently widely used in cancer patients. Perioperative and long-term morbidity of 750 consecutive implants performed from 1985 to 1994 were retrospectively reviewed. Our Series consisted in 616 (82.1%). Ports and 134 (17.9%) external tunnelled catheters with subcutaneous Dacron cuff (Hickmann or similar catheters) implanted by percutaneous access route in local anesthesia. Subclavian vein was the elective access route in 700 (93.3%) patients while in the remaining 50 (6.7%) the access was performed in the femoral vein, due to peculiar clinical conditions. One-day surgery was only required for 19 (2.6%) patients while outpatient surgey was the routine in 731 (97.4%) patients. Perioperative morbidity was at all similar both for Port and external catheters Series (p > 0.07). Late morbidity requiring the removal of the device occurred in 27/134 patients (18.7%) and in 40/616 (6.5%) for external catheters and Port Series, respectively (p <0.002). The rate of infection, 2.3% for ports (p <0.002). Patient's compliance was higher for Ports compared to external cathethers. Apart from peculiar clinical conditions such as hemathologic cancers, bone marrow transplantation or short life expectancy, Ports seem to guarantee for a lower morbidity coupled with better long-term results.

AB - Totally implantable central venous accesses systems are presently widely used in cancer patients. Perioperative and long-term morbidity of 750 consecutive implants performed from 1985 to 1994 were retrospectively reviewed. Our Series consisted in 616 (82.1%). Ports and 134 (17.9%) external tunnelled catheters with subcutaneous Dacron cuff (Hickmann or similar catheters) implanted by percutaneous access route in local anesthesia. Subclavian vein was the elective access route in 700 (93.3%) patients while in the remaining 50 (6.7%) the access was performed in the femoral vein, due to peculiar clinical conditions. One-day surgery was only required for 19 (2.6%) patients while outpatient surgey was the routine in 731 (97.4%) patients. Perioperative morbidity was at all similar both for Port and external catheters Series (p > 0.07). Late morbidity requiring the removal of the device occurred in 27/134 patients (18.7%) and in 40/616 (6.5%) for external catheters and Port Series, respectively (p <0.002). The rate of infection, 2.3% for ports (p <0.002). Patient's compliance was higher for Ports compared to external cathethers. Apart from peculiar clinical conditions such as hemathologic cancers, bone marrow transplantation or short life expectancy, Ports seem to guarantee for a lower morbidity coupled with better long-term results.

KW - Central venous access

KW - Infection

KW - Neoplasms

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=0029795640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029795640&partnerID=8YFLogxK

M3 - Articolo

C2 - 8992390

AN - SCOPUS:0029795640

VL - 51

SP - 427

EP - 431

JO - Minerva Chirurgica

JF - Minerva Chirurgica

SN - 0026-4733

IS - 6

ER -